Table 1.
Characteristic
|
n
|
%
|
---|---|---|
Gender | ||
Male | 22 | 37 |
Female | 38 | 63 |
Age (years) | ||
Median | 61 | |
Range | 30–82 | |
Race | ||
White | 52 | 88 |
Black or African ancestry | 5 | 8 |
Hispanic | 2 | 4 |
Performance status | ||
0 | 19 | 32 |
1 | 37 | 62 |
2 | 4 | 7 |
Diagnosis | ||
Carcinoid | 30 | 50 |
pNET | 30 | 50 |
Elevated baseline chromogrinin A | ||
No | 10 | 17 |
Yes | 48 | 80 |
Unknown | 2 | 3 |
Baseline chromogrinin A | ||
Median | 474 | |
Range | 2–72 400 | |
Primary site | ||
Small bowel | 20 | 33 |
Pancreas | 30 | 50 |
Rectal | 1 | 2 |
Lung | 6 | 10 |
Gastric | 1 | 2 |
Unknown | 2 | 3 |
Grade | ||
Low | 53 | 88 |
Intermediate | 5 | 8 |
Unspecified | 2 | 3 |
Concurrent sandostatin | ||
No | 26 | 43 |
Yes | 34 | 57 |
Prior lines of therapy | ||
Median | 2 | |
Range | 0–9 | |
Octreoscan positivity | ||
No | 9 | 15 |
Yes | 36 | 40 |
Unspecified | 15 | 25 |